Literature DB >> 35484314

Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site.

Kyoko Ishida1,2,3, Kazuki Sato4, Hirokazu Komatsu5, Tatsuya Morita6, Tatsuo Akechi7,8, Megumi Uchida7,8, Kento Masukawa9, Naoko Igarashi9, Yoshiyuki Kizawa10, Satoru Tsuneto11, Yasuo Shima12, Mitsunori Miyashita9, Shoko Ando4.   

Abstract

PURPOSE: Cancer of unknown primary site (CUP) is an aggressive disease with poor prognosis. As research on the experiences of CUP patients and their families is scarce, this study aimed to compare the family caregiver-perceived burden of CUP with that of common cancers (lung, colon, and stomach cancers). The association between family caregiver-perceived burden and CUP patients' quality of life (QOL) at end-of-life and family depression, respectively, was also explored.
METHODS: This was a pre-planned secondary analysis of nationwide cross-sectional survey data from the bereaved family caregivers of patients with cancer who died at 286 institutions. The major measurements were the eight-item family caregiver-perceived Burden scale (comprising specialist access, uncertainty, and prolonged diagnosis), Good Death Inventory, and Patient Health Questionnaire 9.
RESULTS: Of 27,591 survey responses, we analyzed 97 and 717 responses from family caregivers of patients with CUP and common cancer, respectively. The families of CUP patients scored significantly higher on all three burden subscales than those of common cancer patients (effect sizes: specialist access subscale, 0.3; uncertainty subscale, 0.66; and prolonged diagnosis subscale, 0.69; adjusted P < 0.01). Greater family burden was significantly associated with lower patient QOL and higher family depression. Burden was significantly associated with being a spouse, second opinion consultation, and diagnosis period of > 1 month.
CONCLUSION: The family caregivers of CUP patients experience poor specialist access, greater uncertainty, and a prolonged diagnosis. They should be cared for from the initial stages to establish access to specialists, obtain an early diagnosis, and reduce uncertainty.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Burden; Early diagnosis; Experience; Family caregivers; Uncertainty; Unknown primary tumors

Mesh:

Year:  2022        PMID: 35484314     DOI: 10.1007/s00520-022-07070-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

1.  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  K Fizazi; F A Greco; N Pavlidis; G Daugaard; K Oien; G Pentheroudakis
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

Review 2.  New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

Authors:  Elie Rassy; Pauline Parent; Felix Lefort; Stergios Boussios; Giulia Baciarello; Nicholas Pavlidis
Journal:  Crit Rev Oncol Hematol       Date:  2020-01-23       Impact factor: 6.312

Review 3.  Cancer of unknown primary site.

Authors:  Nicholas Pavlidis; George Pentheroudakis
Journal:  Lancet       Date:  2012-03-12       Impact factor: 79.321

4.  The currently declining incidence of cancer of unknown primary.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Cancer Epidemiol       Date:  2019-06-26       Impact factor: 2.984

5.  Psychological burden on patients with cancer of unknown primary: from onset of symptoms to initial treatment.

Authors:  Kyoko Ishida; Shoko Ando; Hirokazu Komatsu; Shiori Kinoshita; Yoshinori Mori; Tatsuo Akechi
Journal:  Jpn J Clin Oncol       Date:  2016-05-20       Impact factor: 3.019

6.  Patients' experiences of carcinoma of unknown primary site: dealing with uncertainty.

Authors:  Lucy Boyland; Carol Davis
Journal:  Palliat Med       Date:  2008-03       Impact factor: 4.762

7.  Uncertainty and anxiety in the cancer of unknown primary patient journey: a multiperspective qualitative study.

Authors:  A Richardson; R Wagland; R Foster; J Symons; C Davis; L Boyland; C Foster; J Addington-Hall
Journal:  BMJ Support Palliat Care       Date:  2013-11-19       Impact factor: 3.568

8.  Pre-referral GP consultations in patients subsequently diagnosed with rarer cancers: a study of patient-reported data.

Authors:  Silvia C Mendonca; Gary A Abel; Georgios Lyratzopoulos
Journal:  Br J Gen Pract       Date:  2016-03       Impact factor: 5.386

9.  SEOM clinical guideline on unknown primary cancer (2017).

Authors:  F Losa; G Soler; A Casado; A Estival; I Fernández; S Giménez; F Longo; R Pazo-Cid; J Salgado; M Á Seguí
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

Review 10.  Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?

Authors:  Elie Rassy; Tarek Assi; Nicholas Pavlidis
Journal:  Br J Cancer       Date:  2020-02-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.